Coculture model of a liver sinusoidal endothelial cell barrier and HepG2/C3a spheroids-on-chip in an advanced fluidic platform

Archive ouverte

Messelmani, Taha | Le Goff, Anne | Soncin, Fabrice | Souguir, Zied | Merlier, Franck | Maubon, Nathalie | Legallais, Cécile | Leclerc, Eric | Jellali, Rachid

Edité par CCSD ; Elsevier -

International audience. The liver is one of the main organs involved in the metabolism of xenobiotics and a key organ in toxicity studies. Prior to accessing the hepatocytes, xenobiotics pass through the hepatic sinusoid formed by liver sinusoidal endothelial cells (LSECs). The LSECs barrier regulates the kinetics and concentrations of the xenobiotics before their metabolic processing by the hepatocytes. To mimic this physiological situation, we developed an in vitro model reproducing an LSECs barrier in coculture with a hepatocyte biochip, using a fluidic platform. This technology made dynamic coculture and tissue crosstalk possible. SK-HEP-1 and HepG2/C3a cells were used as LSECs and as hepatocyte models, respectively. We confirmed the LSECs phenotype by measuring PECAM-1 and stabilin-2 expression levels and the barrier's permeability/transport properties with various molecules. The tightness of the SK-HEP-1 barrier was enhanced in the dynamic coculture. The morphology, albumin secretion, and gene expression levels of markers of HepG2/C3a were not modified by coculture with the LSECs barrier. Using acetaminophen, a well-known hepatotoxic drug, to study tissue crosstalk, there was a reduction in the expression levels of the LSECs markers stabilin-2 and PECAM-1, and a modification of those of CLEC4M and KDR. No HepG2/C3a toxicity was observed. The metabolisation of acetaminophen by HepG2/C3a monocultures and cocultures was confirmed. Although primary cells are required to propose a fully relevant model, the present approach highlights the potential of our system for investigating xenobiotic metabolism and toxicity.

Suggestions

Du même auteur

Investigation of the metabolomic crosstalk between liver sinusoidal endothelial cells and hepatocytes exposed to paracetamol using organ-on-chip technology

Archive ouverte | Messelmani, Taha | CCSD

International audience. Organ-on-chip technology is a promising in vitro approach recapitulating humanphysiology for the study of responses to drug exposure. Organ-on-chip cell cultureshave paved new grounds for tes...

Development of an advanced liver organ-on-chip integrating hydroscaffold mimicking cell matrix

Archive ouverte | Messelmani, Taha | CCSD

International audience. The 3R guidelines recommend the replacement of animal testing with alternative models. One of the proposed solutions is organ-on-chip technology in which liver-on-chip is one of the promising...

Contrôle découlement et suivi de prolifération dans des biopuces hépatiques

Archive ouverte | Messelmani, Taha | CCSD

International audience. Liver biochips are microfluidic chambers containing hepatocytes. In these bioreactors, hepatocytes,which are adherent cells, can be exposed to a flowing culture medium that provides oxygen an...

Chargement des enrichissements...